Literature DB >> 25843739

Merkel cell polyomavirus in merkel cell carcinoma: clinical and therapeutic perspectives.

Mahtab Samimi1, Charlotte Gardair2, Jérome T J Nicol3, Francoise Arnold3, Antoine Touzé3, Pierre Coursaget4.   

Abstract

Merkel cell carcinoma (MCC) is a rare and often aggressive cutaneous cancer with a poor prognosis. The incidence of this cancer increases with age, immunodeficiency and sun exposure. Merkel cell polyomavirus (MCPyV), a new human polyomavirus identified in 2008, is detected in the majority of the MCCs and there is a growing body of evidence that healthy human skin harbors resident or transient MCPyV. A causal link between MCPyV and MCC has been evidenced and this is the first polyomavirus to be clearly implicated as a causal agent underlying a human cancer, and MCPyV was recently classified as a 2A carcinogen. MCC is thus a rare tumor caused by a very common viral skin infection. The aim of this review is to provide a basic overview of the epidemiological, clinical, and pathological characteristics of MCC, to present the current knowledge on MCPyV polyomavirus and its causal association with MCC development, and to describe the therapeutic implications of this causal link.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25843739     DOI: 10.1053/j.seminoncol.2014.12.021

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  8 in total

Review 1.  Molecular Mechanisms of Merkel Cell Polyomavirus Transformation and Replication.

Authors:  Wei Liu; Jianxin You
Journal:  Annu Rev Virol       Date:  2020-06-30       Impact factor: 10.431

Review 2.  Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy.

Authors:  Suzanne L Topalian; Janis M Taube; Robert A Anders; Drew M Pardoll
Journal:  Nat Rev Cancer       Date:  2016-04-15       Impact factor: 60.716

Review 3.  Viral Oncology: Molecular Biology and Pathogenesis.

Authors:  Uyen Ngoc Mui; Christopher T Haley; Stephen K Tyring
Journal:  J Clin Med       Date:  2017-11-29       Impact factor: 4.241

Review 4.  Human polyomaviruses and cancer: an overview.

Authors:  José Carlos Mann Prado; Telma Alves Monezi; Aline Teixeira Amorim; Vanesca Lino; Andressa Paladino; Enrique Boccardo
Journal:  Clinics (Sao Paulo)       Date:  2018-10-11       Impact factor: 2.365

5.  Downregulation of the stress-induced ligand ULBP1 following SV40 infection confers viral evasion from NK cell cytotoxicity.

Authors:  Yoav Bauman; Nir Drayman; Orly Ben-Nun-Shaul; Alon Vitenstein; Rachel Yamin; Yael Ophir; Ariella Oppenheim; Ofer Mandelboim
Journal:  Oncotarget       Date:  2016-03-29

6.  RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells.

Authors:  Sonja Hesbacher; Lisa Pfitzer; Katharina Wiedorfer; Sabrina Angermeyer; Andreas Borst; Sebastian Haferkamp; Claus-Jürgen Scholz; Marion Wobser; David Schrama; Roland Houben
Journal:  Oncotarget       Date:  2016-05-31

7.  p53 elevation in human cells halt SV40 infection by inhibiting T-ag expression.

Authors:  Nir Drayman; Orly Ben-Nun-Shaul; Veronika Butin-Israeli; Rohit Srivastava; Ariel M Rubinstein; Caroline S Mock; Ela Elyada; Yinon Ben-Neriah; Galit Lahav; Ariella Oppenheim
Journal:  Oncotarget       Date:  2016-08-16

Review 8.  Merkel Cell Carcinoma: New Trends.

Authors:  Ellen M Zwijnenburg; Satish F K Lubeek; Johanna E M Werner; Avital L Amir; Willem L J Weijs; Robert P Takes; Sjoert A H Pegge; Carla M L van Herpen; Gosse J Adema; Johannes H A M Kaanders
Journal:  Cancers (Basel)       Date:  2021-03-31       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.